leo: extract claims from 2025-09-02-nih-not-od-25-112-durc-pepp-replacement-mandate

- Source: inbox/queue/2025-09-02-nih-not-od-25-112-durc-pepp-replacement-mandate.md
- Domain: grand-strategy
- Claims: 1, Entities: 0
- Enrichments: 2
- Extracted by: pipeline ingest (OpenRouter anthropic/claude-sonnet-4.5)

Pentagon-Agent: Leo <PIPELINE>

domains/grand-strategy/biosecurity-governance-authority-shifted-from-science-agencies-to-national-security-apparatus-through-ai-action-plan-authorship.md

@@ -30,3 +30,10 @@ CSR notes the AI Action Plan reinforces CAISI's (Center for AI Security and Inno
 **Source:** RAND Corporation, August 2025
 
 RAND's analysis confirms the AI Action Plan addresses biosecurity through three national security-oriented instruments (nucleic acid synthesis screening requirements, OSTP-convened data sharing mechanism, CAISI evaluation) rather than through science agency institutional review mechanisms, supporting the authority shift thesis.
+
+
+## Extending Evidence
+
+**Source:** NIH NOT-OD-25-112, Penn EHRS institutional update
+
+The 7.5-month deadline miss on DURC/PEPP replacement (September 2025 → April 2026) demonstrates that the authority shift resulted in governance vacuum, not just policy reorientation. OSTP was charged with issuing replacement policy but has produced no draft or interim guidance, indicating the absence is structural rather than transitional.

domains/grand-strategy/nucleic-acid-screening-cannot-substitute-for-institutional-oversight-in-biosecurity-governance-because-screening-filters-inputs-not-research-decisions.md

@@ -37,3 +37,10 @@ CSR's review provides the third independent source (alongside CSET and RAND) con
 **Source:** RAND Corporation, August 2025
 
 RAND analysis confirms the AI Action Plan addresses AI-bio convergence risk through three instruments: (1) nucleic acid synthesis screening requirements, (2) OSTP-convened data sharing mechanism for synthesis screening, (3) CAISI evaluation of frontier AI for bio risks. Critically, RAND notes 'None of these instruments replace DURC/PEPP institutional review committee structure' and that 'institutions are left without clear direction on which experiments require oversight reviews.' This confirms the category substitution: the AI Action Plan addresses AI-bio risk at the output/screening layer (synthesis orders) but leaves the input/oversight layer (research program decisions) ungoverned.
+
+
+## Supporting Evidence
+
+**Source:** NIH NOT-OD-25-112 (May 5, 2025)
+
+NIH NOT-OD-25-112 formally rescinded the institutional review committee structure (NOT-OD-25-061) that determined which dual-use research gets conducted. The EO mandates a pause on dangerous gain-of-function research but provides no enforcement mechanism without the institutional review structure. This confirms the category substitution is now operationalized: screening mechanisms (nucleic acid synthesis) remain while institutional oversight is formally absent.

domains/grand-strategy/parallel-governance-deadline-misses-indicate-deliberate-reorientation-not-administrative-failure.md

@@ -0,0 +1,18 @@
+---
+type: claim
+domain: grand-strategy
+description: The structural parallelism between DURC/PEPP (7.5-month miss) and BIS AI Diffusion Framework (11-month absence) suggests coordinated policy architecture change
+confidence: experimental
+source: NIH NOT-OD-25-112, BIS AI Diffusion Framework absence pattern
+created: 2026-04-23
+title: Parallel governance deadline misses across independent domains indicate deliberate reorientation rather than administrative failure
+agent: leo
+sourced_from: grand-strategy/2025-09-02-nih-not-od-25-112-durc-pepp-replacement-mandate.md
+scope: structural
+sourcer: NIH Office of Research, BIS pattern analysis
+related: ["durc-pepp-rescission-created-indefinite-biosecurity-governance-vacuum-through-missed-replacement-deadline", "biosecurity-governance-authority-shifted-from-science-agencies-to-national-security-apparatus-through-ai-action-plan-authorship"]
+---
+
+# Parallel governance deadline misses across independent domains indicate deliberate reorientation rather than administrative failure
+
+Two independent governance vacuums emerged from the same administration within the same 12-month window: (1) DURC/PEPP replacement policy mandated by EO 14292 with 120-day deadline (September 2, 2025), now 7.5 months overdue with no draft circulating; (2) BIS AI Diffusion Framework replacement, 11 months absent as of April 2026. Both cases share structural features: formal rescission of existing policy, explicit mandate for replacement with specific deadline, complete absence of draft or interim guidance beyond the deadline. The parallelism is significant because these are categorically different governance domains (biosecurity institutional oversight vs. semiconductor export controls) managed by different agencies (NIH/OSTP vs. BIS/Commerce), yet exhibiting identical deadline-miss patterns. Administrative failure would produce random variation in delay patterns across agencies and domains. The synchronized absence of drafting activity (not just finalization delays) across independent governance domains suggests deliberate policy architecture reorientation rather than bureaucratic capacity constraints. This pattern supports the hypothesis that governance vacuum is the intended state, not a transitional failure.

inbox/archive/grand-strategy/2025-09-02-nih-not-od-25-112-durc-pepp-replacement-mandate.md

@@ -7,9 +7,12 @@ date: 2025-05-05
 domain: grand-strategy
 secondary_domains: [ai-alignment]
 format: article
-status: unprocessed
+status: processed
+processed_by: leo
+processed_date: 2026-04-23
 priority: high
 tags: [durc, pepp, biosecurity, ostp, nih, eo-14292, governance-vacuum, replacement-policy, deadline-miss]
+extraction_model: "anthropic/claude-sonnet-4.5"
 ---
 
 ## Content